Page last updated: 2024-08-17

dimethylformamide and Prostatic Neoplasms

dimethylformamide has been researched along with Prostatic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abedi, A; Amani, V; Bozorgmehr, M; Lighvan, ZM; Mirzadegan, E; Mohammadi, F; Safari, N; Shahsavar, F; Zarnani, AH1
Fayerweather, WE; Gilby, PG; Pell, S; Walrath, J1

Other Studies

2 other study(ies) available for dimethylformamide and Prostatic Neoplasms

ArticleYear
A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines.
    Anti-cancer agents in medicinal chemistry, 2016, Volume: 16, Issue:3

    Topics: 2,2'-Dipyridyl; Amniotic Fluid; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cisplatin; Dimethylformamide; DNA; Drug Resistance, Neoplasm; Epithelial Cells; Female; Humans; Intercalating Agents; Male; MCF-7 Cells; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Prostatic Neoplasms; Spectrophotometry

2016
A case-control study of cancer among du pont employees with potential for exposure to dimethylformamide.
    Journal of occupational medicine. : official publication of the Industrial Medical Association, 1989, Volume: 31, Issue:5

    Topics: Adult; Aged; Chemical Industry; Cohort Studies; Dimethylformamide; Evaluation Studies as Topic; Facial Neoplasms; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Occupational Diseases; Pharyngeal Neoplasms; Prostatic Neoplasms; Regression Analysis; Risk Factors; Sampling Studies; Skin Neoplasms; Testicular Neoplasms; Time Factors

1989